Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L George

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
International Journal of Clinical Oncology|August 21, 2015
Research misconduct and data fraud in clinical trials: prevalence and causal factorsStephen L George
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Statistical issues in translational cancer researchStephen L George
Journal of the National Cancer Institute|September 18, 2003
Selection bias, phase II trials, and the FDA accelerated approval processStephen L George
Clinical Trials (London, England)|March 17, 2023
Commentary on Harun et al.: The use of historical controls in randomized clinical trialsStephen L George
International Journal of Clinical Oncology|June 4, 2016
Prevalence of data fraudStephen L George
Journal of the National Cancer Institute|January 18, 2007
Response rate as an endpoint in clinical trialsStephen L George
Clinical Investigation|March 3, 2015
Data fraud in clinical trialsStephen L George, Marc Buyse
Clinical Trials (London, England)|June 27, 2023
Futility monitoring for randomized clinical trials with non-proportional hazards: An optimal conditional power approachXiaofei Wang, Stephen L George
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Clinical trials data collection: when less is moreDaniel J Sargent, Stephen L George
Clinical Trials (London, England)|January 21, 2006
A general formulation for a one-sided group sequential designBarry K Moser, Stephen L George
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
International Journal of Clinical Oncology|August 21, 2015
Research misconduct and data fraud in clinical trials: prevalence and causal factorsStephen L George
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Statistical issues in translational cancer researchStephen L George
Journal of the National Cancer Institute|September 18, 2003
Selection bias, phase II trials, and the FDA accelerated approval processStephen L George
Clinical Trials (London, England)|March 17, 2023
Commentary on Harun et al.: The use of historical controls in randomized clinical trialsStephen L George
International Journal of Clinical Oncology|June 4, 2016
Prevalence of data fraudStephen L George
Journal of the National Cancer Institute|January 18, 2007
Response rate as an endpoint in clinical trialsStephen L George
Clinical Investigation|March 3, 2015
Data fraud in clinical trialsStephen L George, Marc Buyse
Clinical Trials (London, England)|June 27, 2023
Futility monitoring for randomized clinical trials with non-proportional hazards: An optimal conditional power approachXiaofei Wang, Stephen L George
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Clinical trials data collection: when less is moreDaniel J Sargent, Stephen L George
Clinical Trials (London, England)|January 21, 2006
A general formulation for a one-sided group sequential designBarry K Moser, Stephen L George
Pageof 6